Molnupiravir, the first oral anti-Covid drug, has major safety concerns, said the head of the Indian Council of Medical Research on Wednesday. Thirteen Indian pharmaceutical companies, including Cipla, Sun Pharma and Dr Reddy’s Laboratories, are manufacturing the drug, which is being developed by US-based biotechnology company Ridgeback Biotherapeutics in collaboration with American pharma giant Merck. Bhargava clarified that while the …
Both the covid-19 vaccines Covishield and Covaxin approved for emergency use in India are safe for patients on blood thinners, Indian Council of Medical Research’s Director General Balram Bhargava said on Thursday. The ICMR chief said that the health ministry has written to the drug controller general of India and both the vaccine manufacturers to correct the factsheet that has …
In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research chief Balram Bhargava said on Tuesday. "In a pandemic situation, restricted use is considered based on safety and immunogenicity data while phase three clinical trail is still ongoing. The phase one …
After questions were raised from various quarters regarding approval of Bharat Biotech's Covaxin and Oxford's Covishield, the Indian Council for Medical Research on Sunday assured that the two anti-coronavirus vaccines have greater efficacy and are safer than other vaccines conducting trials. However, ICMR chief Balram Bhargava, in an exclusive interview to India Today, said the emergency use authorisation was given …
)
